Helicobacter pylori infection and vitamin D
DOI:
https://doi.org/10.22141/2312-413x.8.3-4.2020.212655Keywords:
Helicobacter pylori, vitamin D, immune systemAbstract
The review examines the role of vitamin D in the pathogenesis of Helicobacter pylori-associated gastrointestinal diseases and its impact on the effectiveness of eradication therapy. Current data on the mechanism of interaction between vitamin D, Helicobacter pylori and the immune system are presented.Downloads
References
Peng C, Hu Y, Ge Zhong-Ming [et al]. Diagnosis and Treatment of Helicobacter pylori Infections in Children and Elderly Populations. Chronic Dis Transl Med. 2020;5 (4):243-251. doi: 10.1016/j.cdtm.2019.12.003.
Hooi JKY, Lai WY, Ng WK [et al]. Global Prevalence of Helicobacter Pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017; 153 (2):420-429. doi:10.1053/j.gastro.2017.04.022.
Zamani M, Ebrahimtabar F, Zamani V [et al]. Systematic Review With Meta-Analysis: The Worldwide Prevalence of Helicobacter Pylori Infection Aliment Pharmacol Ther. 2018; 47(7):868-876. DOI: 10.1111/apt.14561.
Malfertheiner P, Megraud F, O'morain CA [et al]. Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report. Gut. 2017;66(1):6‐30. doi:10.1136/gutjnl-2016-312288.
Liu WZ, Xie Y, Lu H [et al]. Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter. 2018;23(2):e12475. doi:10.1111/hel.12475.
Kalach N, Bontems P, Raymond J. Helicobacter Pylori Infection in Children Helicobacter. 2017;22(12): 3. doi:10.1111/hel.12414.
Melby KK, Carlsen LK, Håland G [et al].Helicobacter pylori in early childhood and asthma in adolescence. BMC Research Notes. 2020;13:1. doi 10.1186/s13104-020-04941-6.
Cisarò F, Pizzol A, Pinon M, Calvo PL. Diagnosis and treatment of Helicobacter pylori in the pediatric population. Minerva Pediatrica. 2018; 70:5. doi 10.23736/S0026-4946.18.05346-X.
Sokwala A, Shah MV, Devani S, Yonga G. Helicobacter pylori eradication: a randomised comparative trial of 7‐day versus 14‐day triple therapy. S Afr Med J. 2012;102(6 Pt 2):368‐371. doi: 10.7196/samj.5302.
Chen L, Xu W, Lee A [et al]. The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial. BioMedicine.2018;3 5:87-96. doi:10.1016/j.ebiom.2018.08.028.
D'Elios MM, Czinn SJ. Immunity, Inflammation, and Vaccines for Helicobacter Pylori.Helicobacter 2014; 19(1):19-26. doi:10.1111/hel.12156.
Abaturov OYe, Herasymenko OM. Modulation of TLR4 activity of gastric epitheliocytes in Helicobacter infection (Review). Sovremennaia pedyatryia. 2009;6 (28):141-146.
Dixon BR Hossain R, Patel RV, Scott HM. Al good Th17 Cells in Helicobacter Pylori Infection: A Dichotomy of Help and Harm. Infect Immun. 2019; 87 (11):122. doi:10.1128/IAI.00363-19.
Bagheri N, Salimzadeh L, Shirzad H. The Role of T Helper 1-cell Response in Helicobacter Pylori-Infection. Microb Pathog. 2018;123:1-8. doi:10.1016/j.micpath.2018.06.033.
Dixon BR, Radin JN, Piazuelo MB [et al].IL-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense Against Helicobacter Pylori. PLoS One. 2016;.11(2):e0148514. doi:10.1371/journal.pone.0148514.
Sanaii A, Shirzad H, Haghighian M (et al). Role of Th22 Cells in Helicobacter Pylori-Related Gastritis and Peptic Ulcer Diseases. Mol Biol Rep. 2019; 46 (6):5703-5712. doi: 10.1007/s11033-019-05004-
Bagheri N, Shirzad H, Mirzaei Y( et al). T-bet+ Cells Polarization in Patients Infected With Helicobacter Pylori Increase the Risk of Peptic Ulcer Development. Arch Med Res. 2019;50 (3):113-121. doi:10.1016/j.arcmed.2019.07.005.
Lu YC. LPS/TLR4 signal transduction pathway.Cytokine. 2008;42(2):145-51. doi: 10.1016/j.cyto.2008.01.006.
Brandt S, Kwok T, Hartig R, König W, Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl Acad. Sci. USA. 2005;102(26):9300-5.
Yang ZM, Chen WW, Wang YF. Gene expression profiling in gastric mucosa from Helicobacter pylori-infected and uninfected patients undergoing chronic superficial gastritis. PLoS One. 2012;7(3): e33030. doi:10.1371/journal. pone.0033030.
Bagheri N, Salimzadeh L, Shirzad H. The Role of T Helper 1-cell Response in Helicobacter Pylori-Infection. Microb Pathog. 2018; 123:1-8 .doi: 10.1016/j.micpath.2018.06.033.
Kim SY, Min CH, Oh DJ, Choi HG. Reciprocal association between depression and peptic ulcers: two longitudinal follow-up studies using a national sample cohort. Sci rep. 2020; 10 (1):1749. doi:10.1038/s41598-020-58783-0.
Hernández C, Serrano C, Einisman H (et al]. Peptic Ulcer Disease in Helicobacter Pylori-Infected Children: Clinical Findings and Mucosal Immune Response.J Pediatr Gastroenterol Nutr. 2014;59 (6):773-8. doi: 10.1097/MPG.0000000000000500.
Darma A, Nugroho BST, Yoanna V (et al). Comparison of Helicobacter pylori Stool Antigen, Salivary IgG, Serum IgG, and Serum IgM as Diagnostic Markers of H. pylori Infection in Children. Iran J Microbiol. 2019;11 (3):206-211. Jun 2019.
Abaturov OYe, Gerasymenko OM. Structural organization of innate immune factors in gastric mucosal inflammation at H.pylori infection in children. Zdorove rebenka. 2015;1(60):77-80.
Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010 Aug;10(4):482-96. doi: 10.1016/j.coph.2010.04.001.
Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881–886. doi:10.2310/JIM.0b013e31821b8755.
Korf H, Decallonne B, Mathieu C. Vitamin D for infections. Curr Opin Endocrinol Diabetes Obes. 2014 Dec;21(6):431-6. doi: 10.1097/MED.0000000000000108.
El Shahawy MS, Hemida MH, El Metwaly I, Shady ZM. The effect of vitamin D deficiency on eradication rates of Helicobacter pylori infection. JGH Open. 2018;2(6):270‐275.
Vertegel AA, Ovcharenko LS. Influence of vitamin d on the immune system: double jeopardy of development of osteogenesis disorders in children with recurrent bronchitis Perinatologiya i Pediatriya. 2015.3(63):7174;doi10.15574/PP.2015.63.71.
Zosky GR, Berry LJ, Elliot JG. Vitamin D deficiency causes deficits in lung function and alters lung structure // Am. J. Respir. Crit. Care Med. 2011;183(10):1336-1343.
Magnus MC, Stene LC, Haberg SE. Prospective study of maternal mid-pregnancy 25-hydroxyvitamin D level and early childhood respiratory disorders. Paediatr. Perinat. Epidemiol.2013;27, (6):532-541.
Saraf R, Morton SM, Camargo CAJ, Grant CC. Global summary of maternal and newborn vitamin D status — a systematic review. Matern. Child Nutr. 2016; 12 (4):647-68. doi: 10.1111/mcn.12210.
Recommendations for the admission of vitamin D and the treatment of its deficiency in Central Europe. Journal. Hrodna honey. Universities Universities. 2014; 2: 109–118.
Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev. Endocr. Metab. Disord. 2017;18:153–165. doi: 10.1007/s11154-017-9424-1.
Vitamin D Deficiency And Deficiency: Epidemiology, Diagnosis, Prevention And Treatment. Za red. prof. V.V. Povorozniuka, prof. P. Pludovski. — Donetsk: Vydavets Zaslavskyi O.Iu.
Kvashnina LV. Immunomodulatory effects of vitamin D in children. Zdorove rebenka. 2013;7:134—139.
Scolletta S, Colletti M, Di Luigi L, Crescioli C. Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation. Mediators Inflamm. 2013;1:876319.
Rizzoli R, Boonen S, Brandi MI. Review vitamin D upplementation in elderly or postmenopausal women: a 2013 update of the 2008 recomendations from the European Society for Clinical and Economic Aspects of osteoporosis and Osteoarthritis (ESCEO). Current. Medical. Research. & Opinion. 2013;29:1-9.
Han C, Ni Z, Yuan T [et al]. Influence of serum vitamin D level on Helicobacter pylori eradication: A multi‐center, observational, prospective and cohort study. J Dig Dis. 2019;20:421–426. 10.1111/1751-2980.12793.
CantornaTM, Snyder L, Lin YD, Yang L. Vitamin D and 1,25(OH)2D Regulation of T cells Nutrients. 2015; 7(4): 3011–3021. doi:10.3390/nu7043011.
Chun RF, Hernandez I, Pereira R [et al]. Differential Responses to Vitamin D2 and Vitamin D3 Are Associated With Variations in Free 25-Hydroxyvitamin D. nt J Mol Sci. 2016 Jan; 17(1): 76. Published online 2016 Jan 8. doi: 10.3390/ijms17010076.
Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol. Nutr. Food Res. 2011;55 (1):96–108.
Dima AY. Christopher WT, Miller, Adel M El-Abbassi [et al]. Antimicrobial implications of vitamin D. Dermatoendocrinol. 2011;3 (4):220–229.
Wang G, Narayana J, Mishra B [et al]. Antimicrobial Peptides: Progress Made With Human Cathelicidin LL-37. Adv Exp Med Biol. 2019; 11(17):215-240 doi: 10.1007/978-981-13-3588-4_12.
Penna G, Adorini L. Alpha,25-dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation. J Immunol. 2000;164 (5):2405-11. doi: 10.4049/jimmunol.164.5.2405.
Ginde AA, Mansbach JM, Camargo CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2009;169(4):384-390.
Zosky GR, Berry LJ, Elliot JG. Vitamin D deficiency causes deficits in lung function and alters lung structure. Am. J. Respir. Crit. Care Med. 2011;183(10):1336-1343.
de La Puente-Yagüe M, Cuadrado-Cenzual MA, Ciudad-Cabañas MJ [et al].Vitamin D: And Its Role in Breast Cancer Kaohsiung J Med Sci. 2018; 34 (8), 423-427. doi: 10.1016/j.kjms.2018.03.004
Yin X, Sun Q, Zhang X [et al]. Serum 25(OH)D is inversely associated with metabolic syndrome risk profile among urbanmiddle-aged Chinese population. Nutr J. 2012;11:68–75.
Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23:469–480.
Yildirim O, Yildirim T, Seckin Y [et al]. The influence of vitamin D deficiency on eradication rates of Helicobacter pylori. Adv Clin Exp Med. 2017;26(9):1377‐1381.
Dankers W, Colin EM, van Hamburg JP [et al]. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front. Immunol. 2016;7:697. doi: 10.3389/fimmu.2016.00697.
Chen N, Wan Z, Han SF [et al]. Effect of Vitamin D Supplementation on the Level of Circulating High-Sensitivity C-Reactive Protein: A Meta-Analysis of Randomized Controlled Trials Nutrients. 2014 Jun; 6(6): 2206–2216. Published online 2014 Jun 10. doi:10.3390/nu6062206.
Kawaura A, Takeda E, Tanida N [et al]. Inhibitory effect of long term 1.ALPHA.-Hydroxyvitamin D3 administration on Helicobacter pylori infection. J of Clin cal Biochemistry and Nutrition. 2006; 38(2):73-76. https ://doi.org/10.3164/jcbn.38.103.
Antico A, Tozzoli R, Giavarina D [et al]. Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case–control study and review of the literature on the interaction of Vitamin D: a case–controlstudy and review of the literature on the interaction of Vitamin D with the immune system. Clin Rev Allergy Immunol. 2012; 42:355–364. https ://doi.org/10.1007/s1201 6-011-8255-1.
Yildirim O, Yildirim T, Seckin Y [et al]. The influence of vitamin D deficiency on eradication rates of Helicobacter pylori. Adv Clin Exp Med. 2017;26:1377–1381. https ://doi.org/10.17219 /acem/65430.
Wang TT, Nestel FP, Bourdeau V [et al]. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immuno. 2004;173:2909–2912.
Ramanathan B, Davis EG, Ross CR [et al]. Cathelicidins: microbicidal activity, mechanisms of action, and roles in innateimmunity. Microbes Infect 2002; 4:361–372.
Wehkamp J [et al]. Defensins and Cathelicidins in Gastrointestinal Infections Curr Opin Gastroenterol 23 (1), 32-8.Jan 2007. doi:10.1097/MOG.0b013e32801182c2.
Pero R, Coretti L, Nigro E [et al]. 12β-Defensins in the Fight Against Helicobacter Pylori Molecules. 2017;22 (3):424. doi:10.3390/molecules22030424.
Christakos S, Dhawan P, Verstuyf A [et al]. Carmeliet Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016;96(1): 365–408. doi:10.1152/physrev.00014.2015.
Wanibuchi K, Hosoda K, Ihara M [et al]. Indene compounds synthetically derived from vitamin D have selective antibacterial action on Helicobacter pylori. Lipids. 2018;53(4):393‐401.
Inamo Y, Hasegawa M, Saito K [et al]. Serum vitamin D concentrations and associated severity of acute lower respiratory tract infections in Japanese hospitalized children. Pediatrics International. 2011; 53 (2):199—201.
Gois PHF, Ferreira D, Olenski S, Seguro AC. Vitamin D and infectious diseases: Simple bystander or contributing factor? Nutrients. 2017;9:651 doi: 10.3390/nu9070651.
Del Pinto R, Ferri C, Cominelli F. Vitamin D Axis in Inflammatory Bowel Diseases: Role, Current Uses and Future Perspectives Int J Mol Sci. 2017; 18 (11): 12 doi:10.3390/ijms18112360.
Shimomura H, Hosoda K, Hayashi S [et al]. Steroids mediate resistance to the bactericidal effect of phosphatidylcholines against Helicobacter pylori. FEMS Microbiol Lett. 2009;301(1):84‐94.
Shimomura H, Hosoda K, Hayashi S [et al]. Phosphatidylethanolamine of Helicobacter pylori: function as a steroid‐binding lipid in the assimilation of free‐cholesterol and 3β‐hydroxl steroids into the bacterial cell membrane. J Bacteriol. 2012;194(10):2658‐2667.
Guo L, Chen W, Zhu H [et al]. Helicobacter pylori induces increased expression of the vitamin d receptor in immune responses. Helicobacter. 2014;19:37–47. https ://doi.org/10.1111/hel.12102.
Yildirim O, Yildirim T, Seckin Y [et al]. The influence of vitamin D deficiency on eradication rates of Helicobacter pylori. Adv Clin Exp Med. 2017; 26:1377–1381. https ://doi.org/10.17219 /acem/65430.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 T.V. Sorokman, N.O. Popelyuk, V.G. Ostapchuk
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN 
ISSN 
